Bu sayfanın çevirisi deneyseldir ve geliştirilme aşamasındadır. imlerinizi bekliyoruz!

Perimeter Medical Imaging AI Temettü

Temettü kriter kontrolleri 0/6

Perimeter Medical Imaging AI şirketinin temettü ödeme geçmişi bulunmamaktadır.

Anahtar bilgiler

n/a

Temettü verimi

n/a

Ödeme oranı

Sektör ortalama getirisi	1.7%
Bir sonraki temettü ödeme tarihi	n/a
Eski temettü tarihi	n/a
Hisse başına temettü	n/a
Hisse başına kazanç	-CA$0.13
Temettü verim tahmini	n/a

Son temettü güncellemeleri

Güncelleme yok

Recent updates

Perimeter Medical Imaging AI (CVE:PINK) Will Have To Spend Its Cash Wisely

Jul 15

We're Keeping An Eye On Perimeter Medical Imaging AI's (CVE:PINK) Cash Burn Rate

Mar 23

We Think Perimeter Medical Imaging AI (CVE:PINK) Needs To Drive Business Growth Carefully

Aug 18

We're Not Very Worried About Perimeter Medical Imaging AI's (CVE:PINK) Cash Burn Rate

Apr 26

We Think Perimeter Medical Imaging AI (CVE:PINK) Needs To Drive Business Growth Carefully

Oct 25

Here's Why We're Not Too Worried About Perimeter Medical Imaging AI's (CVE:PINK) Cash Burn Situation

Jun 29

The Director of Perimeter Medical Imaging AI, Inc. (CVE:PINK), Douglas Janzen, Just Bought 60% More Shares

Mar 05

Ödemelerde İstikrar ve Büyüme

Temettü verilerini getirme

İstikrarlı Temettü: PINK şirketinin hisse başına düşen temettülerinin geçmişte istikrarlı olup olmadığını belirlemek için yeterli veri yok.

Büyüyen Temettü: PINK şirketinin temettü ödemelerinin artıp artmadığını belirlemek için yeterli veri yok.

Piyasaya Karşı Temettü Getirisi

Perimeter Medical Imaging AI Piyasaya Karşı Temettü Getirisi

PINK temettü verimi piyasa ile karşılaştırıldığında nasıldır?
Segment	Temettü Verimi
Şirket (PINK)	n/a
Pazarın Alt %25'i (CA)	1.7%
Pazarın En İyi %25'i (CA)	5.8%
Sektör Ortalaması (Medical Equipment)	1.7%
Analist tahmini (PINK) (3 yıla kadar)	n/a

Önemli Temettü: PINK şirketinin temettü getirisi, şirketin yakın zamanda herhangi bir ödeme bildirmemesi nedeniyle, temettü ödeyenlerin en alttaki %25'lik dilimine göre değerlendirilemiyor.

Yüksek Temettü: Şirketin yakın zamanda herhangi bir ödeme bildirmemesi nedeniyle, PINK şirketinin temettü getirisi, temettü ödeyenlerin en üst %25'ine göre değerlendirilemiyor.

Hissedarlara Ödenen Kazanç

Kazanç Kapsamı: PINK şirketinin temettü ödemelerinin kazançlarla karşılanıp karşılanmadığını belirlemek için ödeme oranını hesaplamak üzere yeterli veri yok.

Hissedarlara Nakit Ödeme

Nakit Akışı Kapsamı: PINK herhangi bir ödeme bildirmediğinden temettülerin sürdürülebilirliği hesaplanamıyor.

Perimeter Medical Imaging AI Temettü

Temettü kriter kontrolleri 0/6

Anahtar bilgiler

Son temettü güncellemeleri

Recent updates

New minor risk - Shareholder dilution

Perimeter Medical Imaging AI, Inc. announced that it expects to receive CAD 13.513513 million in funding

Second quarter 2024 earnings: EPS and revenues exceed analyst expectations

Perimeter Medical Imaging AI, Inc. to Report Q2, 2024 Results on Aug 14, 2024

Perimeter Medical Imaging AI (CVE:PINK) Will Have To Spend Its Cash Wisely

First quarter 2024 earnings: EPS exceeds analyst expectations while revenues lag behind

Perimeter Medical Imaging AI, Inc. to Report Q1, 2024 Results on May 14, 2024

Consensus revenue estimates fall by 51%

New major risk - Revenue and earnings growth

Full year 2023 earnings released: US$0.22 loss per share (vs US$0.16 loss in FY 2022)

We're Keeping An Eye On Perimeter Medical Imaging AI's (CVE:PINK) Cash Burn Rate

Price target increased by 15% to CA$4.38

Perimeter Medical Imaging AI, Inc. Announces Results from New Study 1 Published in the Annals of Surgical Oncology

New minor risk - Share price stability

Perimeter Medical Imaging AI, Inc. Announces Expanded Commercial Presence Within National Healthcare Provider System with Follow-On Placement of Perimeter S-Series Oct At Additional Hospital Site

Third quarter 2023 earnings: EPS exceeds analyst expectations while revenues lag behind

Perimeter Medical Imaging AI, Inc. to Report Q3, 2023 Results on Nov 14, 2023

Perimeter Medical Imaging AI, Inc., Annual General Meeting, Dec 06, 2023

Price target increased by 21% to CA$4.63

Perimeter Medical Imaging Ai, Inc. Announces Patient Randomization Underway At Clinical Trial Site At Mayo Clinic in Florida

Perimeter Medical Imaging AI, Inc. Announces Alignment with FDA on Key Elements of Ongoing Clinical Trial

Consensus EPS estimates fall by 17%, revenue upgraded

Second quarter 2023 earnings: Revenues exceed analysts expectations while EPS lags behind

Perimeter Medical Imaging AI, Inc. to Report Q2, 2023 Results on Aug 29, 2023

We Think Perimeter Medical Imaging AI (CVE:PINK) Needs To Drive Business Growth Carefully

Perimeter Medical Imaging Ai, Inc. Announces Executive Changes

First quarter 2023 earnings released: CA$0.05 loss per share (vs CA$0.11 loss in 1Q 2022)

Anthony Holler Resigns as a Director of Perimeter Medical Imaging AI, Inc

Perimeter Medical Imaging AI, Inc. to Report Q1, 2023 Results on May 25, 2023

We're Not Very Worried About Perimeter Medical Imaging AI's (CVE:PINK) Cash Burn Rate

Price target decreased by 12% to CA$3.56

Full year 2022 earnings: EPS in line with expectations, revenues disappoint

Perimeter Medical Imaging Ai, Inc. Announces CFO Changes

Consensus forecasts updated

Consensus forecasts updated

Price target decreased to CA$4.06

Third quarter 2022 earnings: EPS exceeds analyst expectations while revenues lag behind

High number of new directors

Perimeter Medical Imaging AI, Inc. to Report Q3, 2022 Results on Nov 15, 2022

We Think Perimeter Medical Imaging AI (CVE:PINK) Needs To Drive Business Growth Carefully

Perimeter Medical Imaging AI, Inc., Annual General Meeting, Oct 27, 2022

Consensus revenue estimates increase by 56%

Second quarter 2022 earnings: EPS and revenues exceed analyst expectations

Perimeter Medical Imaging AI, Inc. to Report Q2, 2022 Results on Aug 24, 2022

Here's Why We're Not Too Worried About Perimeter Medical Imaging AI's (CVE:PINK) Cash Burn Situation

Perimeter Medical Imaging AI Appoints Kancherla to Board of Directors

Consensus revenue estimates fall by 32%

First quarter 2022 earnings: Revenues miss analyst expectations

Perimeter Medical Imaging Ai Appoints Chris Scott as Chief Financial Officer

Consensus EPS estimates fall by 21%

High number of new directors

Price target decreased to CA$5.42

Perimeter Medical Imaging AI Announces Initiation of Additional Clinical Trial Site at Baylor College of Medicine in Houston, TX

Perimeter Medical Imaging AI Announces Initiation of First Clinical Trial Site At West Cancer Center & Research Institute in Tennessee

Perimeter Medical Imaging AI, Inc. announced that it expects to receive CAD 43.400001 million in funding

High number of new directors

Consensus forecasts updated

Consensus forecasts updated

Director recently bought CA$215k worth of stock

The Director of Perimeter Medical Imaging AI, Inc. (CVE:PINK), Douglas Janzen, Just Bought 60% More Shares

Perimeter Medical Imaging AI Announces U.S. FDA 510(k) Clearance for OCT Imaging System

New 90-day high: CA$4.09

New 90-day high: CA$3.28

New 90-day high: CA$2.90

New 90-day high: CA$2.62

New 90-day high: CA$2.50

Ödemelerde İstikrar ve Büyüme

Piyasaya Karşı Temettü Getirisi

Hissedarlara Ödenen Kazanç

Hissedarlara Nakit Ödeme

Güçlü temettü ödeyen şirketleri keşfedin